We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.125 | 0.69% | 18.125 | 17.75 | 18.50 | 18.125 | 18.00 | 18.00 | 125,995 | 13:24:52 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.38 | 16.52M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/9/2018 06:05 | SOH will do the right deals at the right price at the right price price...I Very much doubt the child like posts by trolls on here will affect his Sound Judgement....Enjoy. (At 40p "Would not touch this share with a barge pole + Rampers Crying again".....At 100p "Would not touch this share with a barge pole + Rampers Crying again" At 150p ????????? | greenas1953 | |
30/9/2018 03:55 | Putting my technical hat on, in the absence of news next week, there are 2 opposing chart forces short term. This won't interest LTHs. On the plus side, the stock broke the neckline of a reverse head and shoulders pattern at 95p. The depth is 10p, so the stock should go to 105p next week. On the minus side, 100p was a strong support level, before we broke to the downside. It could now become a strong resistance level and we could fall back from here. My view is that we could race quickly to 105p and fall back from there..... | onceabroker1 | |
29/9/2018 23:09 | Agreed Parob. More and more deals being signed. Aww..monkey carries so much hatred for Elric. lol, the sign of an insecure man. | 7ilas | |
29/9/2018 22:14 | Start of another bullsh*t run Parob I think you mean! Rampers thread | rayrac | |
29/9/2018 21:38 | Another ramp fest about to start. Is elrampo coming back? | monkeywench1 | |
29/9/2018 21:19 | OPTI is at the start of another bull run. | parob | |
29/9/2018 20:50 | Cash too the bottom line. Come on soh, enough of LPL and Bulgaria and its diminishing population of 7m! Contracts and much cash hitting the bottom line!! And less ramping | rayrac | |
29/9/2018 20:13 | Let's hope so. | monkeywench1 | |
29/9/2018 20:13 | Need revenues. | monkeywench1 | |
29/9/2018 20:09 | One thing's for sure - the next half yearly results should show a significant difference to the last! | cyberbub | |
29/9/2018 17:41 | As the breakout took hold, we went from 65p to 130p, i.e. 100% in one month. The company is now in a much stronger position so I can't see any reason why we can't go up at least 50% during the month of October. The momentum certainly seems to gathering pace. | parob | |
29/9/2018 17:26 | Revenues are required. | monkeywench1 | |
29/9/2018 17:23 | Parob I’m going on soh comments that it’s been the busiest summer ever and a lot going on not in the public domain. S | shrewdmole | |
29/9/2018 16:35 | Deals in quick succession would get the share price motoring now the trend has changed. | parob | |
29/9/2018 15:17 | So 3 deals announced in September. How many are going to be closed in October? My guess is another 3. | parob | |
29/9/2018 14:41 | Ah, fair enough. Thanks | 7ilas | |
29/9/2018 14:34 | The TATA deals are LPGOS and Slimbiome so far. Olliscience hasn't been RNSed yet. | parob | |
29/9/2018 14:21 | We’ve still not had the oilscience rns have we or have I missed something | shrewdmole | |
29/9/2018 14:04 | Parob, does TATA's LP-LDL deal not also fall under the Probiotix branch? | 7ilas | |
29/9/2018 13:52 | ProBiotix Health deals so far:- Sacco- HLH BioPharma Vertriebs GmbH - Nutrilinia- Pharmabiota- Galenicum Special Ingredients - Fine Foods & Pharmaceuticals- Trigen Pharma- Akums Drugs and Pharma- Seed Health- Unnamed US pharma partner - Bened Biomedical- Unnamed Bulgarian CholBiome distributor | parob | |
29/9/2018 13:37 | Adam Reynolds expertise lies in taking companies to listings and I think this is what he'll mainly be used for. Considering how developed Probiotix is I believe it would be a step in the wrong direction to keep him as chairman for too long. He has immense contacts in the city therefore he should aid in pulling off a smooth IPO. I would then expect him to be replaced within the first few years with someone of commercial expertise similar to Neil Davidson of Opti. | riskybusiness1 | |
29/9/2018 12:29 | hTTps://mobile.twitt | parob | |
29/9/2018 12:16 | Simply filter all those that engage. FailedQS 7ilas filtered | john henry | |
29/9/2018 12:10 | Rayrac = buffoon.Discuss..... | failedqs |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions